RayzeBio, Inc.

YTD

ALL

Why Robinhood?

You can watch RayzeBio, Inc. and buy or sell other stocks, ETFs, and their options commission-free!

About RYZB

RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. As the emerging leader in radiopharmaceuticals, RayzeBio is developing an innovative robust pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225.

CEO

Kenneth Song, MD

CEOKenneth Song, MD

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2020

Founded2020

Employees

—

Employees—

RYZB Key Statistics

Market cap

3.74B

Market cap3.74B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

44.41K

Average volume44.41K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$62.51

52 Week high$62.51

52 Week low

$17.95

52 Week low$17.95